EUR 306.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 11.2 Million EUR | 77.64% |
2022 | 4.81 Million EUR | 25.36% |
2021 | 3.84 Million EUR | 18.94% |
2020 | 3.23 Million EUR | 23.4% |
2019 | 2.61 Million EUR | 181.99% |
2018 | -3.19 Million EUR | -38.26% |
2017 | -2.31 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 6.22 Million EUR | 0.0% |
2023 FY | 8.55 Million EUR | 77.64% |
2023 Q2 | 3.22 Million EUR | 0.0% |
2023 Q4 | 5.33 Million EUR | 0.0% |
2022 Q2 | 2.59 Million EUR | 0.0% |
2022 FY | 4.81 Million EUR | 25.36% |
2022 Q4 | 2.22 Million EUR | 0.0% |
2021 FY | 3.84 Million EUR | 18.94% |
2021 Q4 | 2.14 Million EUR | 0.0% |
2021 Q2 | 1.69 Million EUR | 0.0% |
2020 FY | 3.23 Million EUR | 23.4% |
2020 Q4 | 1.66 Million EUR | 0.0% |
2020 Q2 | 1.56 Million EUR | 0.0% |
2019 Q4 | 1.7 Million EUR | 0.0% |
2019 Q2 | 913.77 Thousand EUR | 0.0% |
2019 FY | 2.61 Million EUR | 181.99% |
2018 Q4 | -773.09 Thousand EUR | 0.0% |
2018 FY | -3.19 Million EUR | -38.26% |
2018 Q3 | -773.09 Thousand EUR | 6.16% |
2018 Q1 | -823.8 Thousand EUR | -571.43% |
2018 Q2 | -823.8 Thousand EUR | 0.0% |
2017 Q4 | 174.74 Thousand EUR | 0.0% |
2017 Q1 | 194.31 Thousand EUR | 0.0% |
2017 FY | -2.31 Million EUR | 0.0% |
2017 Q2 | 194.31 Thousand EUR | 0.0% |
2016 Q4 | 194.31 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | 99.685% |
Fresenius SE & Co. KGaA | 3.91 Billion EUR | 99.714% |
M1 Kliniken AG | 16.77 Million EUR | 33.194% |
Maternus-Kliniken Aktiengesellschaft | 17.48 Million EUR | 35.902% |
MEDICLIN Aktiengesellschaft | 70.03 Million EUR | 84.0% |
RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | 93.103% |
VITA 34 AG | 31.36 Million EUR | 64.272% |